MONDAY DEADLINE: NRx Pharmaceuticals, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between...

Related Keywords

San Diego ,California ,United States ,Robbins Geller ,Nrx Pharma ,Dal Bosco ,Enron Corp ,Drug Administration ,Prnewswire Robbins Geller Rudman Dowd ,Nrx Pharmaceuticals Inc ,Nasdaq ,Robbins Geller Rudman Dowd ,Securities Class Action Services Top ,Securities Exchange ,Securities Exchange Act ,Emergency Use Authorization ,Class Period ,Private Securities Litigation Reform Act ,Robbins Geller Rudman ,Class Action Services Top ,Geller Rudman ,Robbins Geller Rudman Amp Dowd Llp ,